FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-27
DOI
10.3389/fendo.2018.00351
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
- (2017) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload
- (2017) Svetlana Slavic et al. Scientific Reports
- Up-regulation of FGF23 release by aldosterone
- (2016) Bingbing Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study
- (2016) Nao Souma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
- (2015) Olena Andrukhova et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation
- (2015) Manfred Richter et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
- (2015) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis
- (2015) Jelmer K. Humalda et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure
- (2015) Ingrid A. Andersen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment
- (2015) Luca Di Lullo et al. CardioRenal Medicine
- Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
- (2015) Peter Wohlfahrt et al. JACC-Heart Failure
- FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability
- (2014) Neerupma Silswal et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2014) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Coupling fibroblast growth factor 23 production and cleavage
- (2014) Myles Wolf et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- FGF23 promotes renal calcium reabsorption through the TRPV5 channel
- (2014) Olena Andrukhova et al. EMBO JOURNAL
- FGF23 regulates renal sodium handling and blood pressure
- (2014) Olena Andrukhova et al. EMBO Molecular Medicine
- Chronic kidney disease and cardiovascular complications
- (2014) Luca Di Lullo et al. HEART FAILURE REVIEWS
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate
- (2014) J. Xie et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- New Insights Into the FGF23-Klotho Axis
- (2014) Hannes Olauson et al. SEMINARS IN NEPHROLOGY
- Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3–4 patients
- (2014) Lee-Moay Lim et al. BMC Nephrology
- Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders
- (2014) Marc G Vervloet et al. Lancet Diabetes & Endocrinology
- FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy
- (2013) Chad D. Touchberry et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism
- (2013) Ming Chang Hu et al. Annual Review of Physiology
- Correlates of left ventricular mass in chronic hemodialysis recipients
- (2013) Ron Wald et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease
- (2013) Shiqin Zhang et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
- (2013) Julia J. Scialla et al. KIDNEY INTERNATIONAL
- Pan-FGFR Inhibition Leads to Blockade of FGF23 Signaling, Soft Tissue Mineralization, and Cardiovascular Dysfunction
- (2013) Gina M. Yanochko et al. TOXICOLOGICAL SCIENCES
- Mechanism of FGF23 processing in fibrous dysplasia
- (2012) Nisan Bhattacharyya et al. JOURNAL OF BONE AND MINERAL RESEARCH
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Update on fibroblast growth factor 23 in chronic kidney disease
- (2012) Myles Wolf KIDNEY INTERNATIONAL
- Expression of fgf23 and klotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio
- (2012) S. Mangos et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sudden Cardiac Death in Hemodialysis Patients: An In-Depth Review
- (2011) Darren Green et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease
- (2011) M. H. de Borst et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease
- (2011) J. Payne et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages
- (2011) L. Desjardins et al. OSTEOPOROSIS INTERNATIONAL
- Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
- (2010) M. G. Vervloet et al. Clinical Journal of the American Society of Nephrology
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
- (2009) G. Jean et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now